These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy. Takahashi Y, Nishikawa M, Takakura Y. Adv Drug Deliv Rev; 2009 Jul 25; 61(9):760-6. PubMed ID: 19386274 [Abstract] [Full Text] [Related]
3. Long-term effects of short hairpin RNA-targeted human telomerase reverse transcriptase on suppression of SGC-7901 cell proliferation by inhibition of telomerase activity. Qian X, Cheng J, Chen A, Wang Y, Tao Y, Cao J, Feng Z. Oncol Rep; 2008 Feb 25; 19(2):575-81. PubMed ID: 18202810 [Abstract] [Full Text] [Related]
4. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies. Vorhies JS, Nemunaitis J. Expert Rev Anticancer Ther; 2007 Mar 25; 7(3):373-82. PubMed ID: 17338656 [Abstract] [Full Text] [Related]
6. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter. Park SY, Kwak W, Thapa N, Jung MY, Nam JO, So IS, Kim SY, Yoo J, Lee J, Kim IS. J Nucl Med; 2008 Sep 25; 49(9):1480-8. PubMed ID: 18703598 [Abstract] [Full Text] [Related]
9. Potential use of RNA interference in cancer therapy. Phalon C, Rao DD, Nemunaitis J. Expert Rev Mol Med; 2010 Aug 18; 12():e26. PubMed ID: 20716384 [Abstract] [Full Text] [Related]
18. An advanced blue-white screening method for construction of shRNA expression vectors. Yang J, Xu J, Zhong X, Zhang Y, Wu Q, Li W, Zhang X, Zhen P, Yang X, Chen L, Wang Y, Zhu D, Zhai C, Ma L. Biochem Biophys Res Commun; 2009 Dec 04; 390(1):97-102. PubMed ID: 19781525 [Abstract] [Full Text] [Related]